Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension

European Respiratory Journal

Volumn 29, Issue 5, 2007, Pages 944-950

  Hoeper, Marius M ^a   Pletz, M W ^a   Golpon, H ^a   Welte, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Blood gases; Carbon dioxide; Hyperventilation; Hypoxia; Pulmonary hypertension

Indexed keywords

BERAPROST; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; ILOPROST; OXYGEN; SILDENAFIL; UNIPROST;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD GAS ANALYSIS; CARBON DIOXIDE TENSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; END TIDAL CARBON DIOXIDE TENSION; EXERCISE; FEMALE; HEART ATRIUM PRESSURE; HEART FAILURE; HEART LUNG TRANSPLANTATION; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HUMAN; HYPOCAPNIA; LUNG DEAD SPACE; LUNG MINUTE VOLUME; LUNG TRANSPLANTATION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIPLE REGRESSION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; REST; SURVIVAL RATE; TIDAL VOLUME; TIME; WALKING;

AREA UNDER CURVE; BLOOD GAS ANALYSIS; CARDIAC OUTPUT, LOW; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE;

EID: 34248158605     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00134506     Document Type: Article

References (17)

1. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-2278.
2. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216-223.
3. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation 2002; 105: 54-60.
4. Hoeper MM, Taha N, Bekjarova A, Gatzke R, Spiekerkoetter E. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids. Eur Respir J 2003; 22: 330-334.
5. Hoeper MM, Markevych I, Spiekerkoetter E, Welte T, Niedermeyer J. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J 2005; 26: 858-863.
6. 2 to exercise hyperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2004; 93: 318-323.
7. Metra M, Dei Cas L, Panina G, Visioli O. Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am J Cardiol 1992; 70: 622-628.
8. Reindl I, Wernecke KD, Opitz C, et al. Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. Am Heart J 1998; 136: 778-785.
9. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001; 104: 429-435.
10. Johnson RL Jr. Gas exchange efficiency in congestive heart failure II. Circulation 2001, 103: 916-918.
11. Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002; 106: 319-324.
12. Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005; 127: 1637-1646.
13. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103: 967-972.
14. Fanfulla F, Mortara A, Maestri R, et al. The development of hyperventilation in patients with chronic heart failure and Cheyne-Strokes respiration: a possible role of chronic hypoxia. Chest 1998; 114: 1083-1090.
15. Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002; 106: 3079-3084.
16. Buller NP, Poole-Wilson PA. Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J 1990; 63: 281-283.
17. Chua TP, Ponikowski P, Harrington D, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997; 29: 1585-1590.